Financial News
Latest News about AstraZeneca PLC
Recent news which mentions AstraZeneca PLC
Friday's big stock stories: What’s likely to move the market in the next trading session
November 14, 2024
From CNBC.com News
Cramer's Lighting Round: 'I'm not going to recommend' Altria
November 14, 2024
From CNBC.com News
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
November 13, 2024
From CNBC.com News
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
November 08, 2024
From CNBC.com News
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
October 17, 2024
From CNBC.com News
Cerebras IPO has 'too much hair' as AI chipmaker tries to sell Wall Street on Nvidia alternative
October 11, 2024
From CNBC.com News
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
September 16, 2024
From CNBC.com News
AstraZeneca shares fall 5% on disappointing lung cancer drug trial results
September 10, 2024
From CNBC.com News
AstraZeneca says staff detained in China amid reports of a drug-import investigation
September 05, 2024
From CNBC.com News
India and Singapore agree to cooperate on chips as countries seek to strengthen partnership
September 05, 2024
From CNBC.com News
India's Modi expected to usher in new era of bilateral agreements in Singapore visit
September 03, 2024
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
From CNBC.com News
Why CEO AstraZeneca believes the pharmaceutical company can almost double revenues by 2030
June 04, 2024
Tickers
CEO
From CNBC.com News
From CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
May 23, 2024
From CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
May 21, 2024
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
May 07, 2024
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
April 30, 2024
From CNBC.com News
From CNBC.com News
Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients
March 26, 2024
From CNBC.com News
Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations
March 13, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
February 27, 2024
From CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
February 10, 2024
From CNBC.com News
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
